Can less lung surgery after immunotherapy be just as safe?
NCT ID NCT07373899
First seen Jan 28, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study looks at people with stage II to IIIB non-small cell lung cancer whose tumors shrank after immunotherapy. It compares two surgery approaches: removing only the shrunken tumor area versus removing the original larger area. The goal is to see if less surgery can preserve lung function without increasing the risk of cancer coming back. About 354 participants will choose which surgery group to join.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGERY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.